ADOT - BIOMODA: Profitable Technology with Purpose Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : ADOT - BIOMODA: Profitable Technology with Purpose

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: BIGFRED who wrote (1862)	10/17/1998 7:05:00 PM
From: Guy.	Read Replies (1) of 4650

Dear Fred,i suspect either i am missing something or we have a misunderstanding. What do you mean by saying <the testing back east>? Which test? The lungcheck results will be out probably by the end of october+ and a PR will come as soon as everything is ready for publish. The only tests that will be done after that will be done as an expanded trial to get an FDA approval(although it is not needed). DARPA,i really hope that the canadian company succeeds,it will be great.But phase3 trials usually takes at least 2 years and till then Biomoda is expected to have its kit distributed all around the world. Biomoda's cure is not expected to be approved so quickly,but as Fred said there is room for several cures and i wish they both will work. Also remember that at the testing segment Biomoda is unique at this stage. Guy

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next